澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

CSL LIMITED

184.810

+0.9700.53%

成交量：59.56万

成交额：1.10亿

市值：885.08亿

市盈率：-24.03

高：185.200

开：184.290

低：183.540

收：183.840

52周最高：216.734

52周最低：88.830

股本：4.79亿

流通股本：4.79亿

量比：0.65

换手率：0.12%

股息：4.12

股息率：2.23%

每股收益(TTM):-7.690

每股收益(LYR):-7.689

净资产收益率：-15.83%

总资产收益率：7.26%

市净率：4.16

市盈率(LYR):-24.03

数据加载中...

总览公司新闻资讯公告

异动解读 | CSL Limited盘中大涨5%，宣布启动下一代免疫球蛋白临床试验

CSL有限公司将开展临床试验，验证下一代Horizon 2工艺生产的免疫球蛋白有效性与安全性

安登布里（Andembry）展现良好安全性；多数患者在12个月治疗期内未出现发作

CSL公布Andembry®治疗儿童遗传性血管性水肿IIIb期积极结果，支持扩大儿科适应症申报

欧盟就赛诺菲针对竞争对手流感疫苗可能存在的反竞争行为征集反馈意见

赛诺菲回应欧盟调查：坚信自身行为始终完全符合所有适用法律法规

赛诺菲就欧盟调查发表声明：在整个过程中与欧盟委员会保持全面合作

分析-2025年，随着高价基因疗法上市数量减少，美国新药价格出现下降

得克萨斯州训练中心爆发疫情后，美军要求部分人员接种流感疫苗

FDA顾问委员会支持莫德纳mRNA流感疫苗

数据简报-全球制药企业斥资数十亿美元以扩大在美国的市场份额

异动解读 | 英国批准AUJEMFLU流感疫苗，CSL LIMITED盘中大涨5.02%

英国MHRA批准AUJEMFLU用于50岁及以上成人流感防护

热门话题-尽管表现欠佳，晨星仍维持对CSL的公允价值评级

澳大利亚TGA：苯青霉素注射剂产品将逐步停产，600毫克规格自11月30日起首当其冲，原因系商业考量

澳大利亚TGA：未来或将有更多本土注册的青霉素钠注射剂品牌上市

澳大利亚TGA：特定苄星青霉素钠注射液产品将持续供应至库存耗尽

CSL加拿大宣布首例加拿大患者于安大略省接受Hemgenix®血友病B基因疗法

泛美卫生组织签署协议为拉美及加勒比地区预留大流行流感疫苗供应

异动解读 | 花旗下调评级与目标价，CSL盘中大跌5.74%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/CSL.AU/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":184.81,"timestamp":1791781920000,"preClose":183.84,"halted":0,"volume":595580,"delay":0,"changeRate":0.005276327241079193,"nameEN":"CSL LIMITED","floatShares":478911979,"shares":478911979,"eps":-7.690599111192875,"marketStatus":"未开盘","change":0.97,"latestTime":"10-12 16:12:00 AEDT","open":184.29,"high":185.2,"low":183.54,"amount":109975624,"amplitude":0.00903,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.690599111192875,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1791846000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":183.84,"dividendRate":0.0223,"openAndCloseTimeList":[[1791759600000,1791781200000]],"volumeRatio":0.6483947336734799,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":183.84,"auctionPrice":184.81,"auctionVolume":153435,"auction":3,"marketStatus":"盘后竞价","timestamp":1791781814033}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":478911979,"roa":"7.26%","roe":"-15.83%","lyrEps":-7.689223,"volumeRatio":0.6483947336734799,"shares":478911979,"dividePrice":4.1213,"high":185.2,"amplitude":0.00903,"preClose":183.84,"low":183.54,"week52Low":88.83,"pbRate":"4.16","psRate":"3.90","week52High":216.734,"institutionHeld":0,"latestPrice":184.81,"eps":-7.690433312876646,"divideRate":0.0223,"volume":595580,"delay":0,"ttmEps":-7.690433312876646,"open":184.29,"prevYearClose":168.21,"prevWeekClose":183.84,"prevMonthClose":184.22,"prevQuarterClose":184.22,"fiveDayClose":176.99,"twentyDayClose":171.57,"sixtyDayClose":121.024,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":5,"dividendGrowthRate":0.003543182641490467,"fiveYearAvgDividendRate":0.01866467227077263},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-10","defaultRemindTime":1788912000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-02","payableDate":"2026-09-10","currency":"USD","dateTimestamp":1788876000000,"payDate":"2026-10-02"},{"date":"2026-08-18","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1137659350","title":"异动解读 | CSL Limited盘中大涨5%，宣布启动下一代免疫球蛋白临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1137659350","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137659350?lang=zh_cn&edition=fundamental","pubTime":"2026-07-29 08:14","pubTimestamp":1785284068,"startTime":"0","endTime":"0","summary":"CSL Limited（CSL.AU）今日盘中股价大涨5%，引发市场关注。消息面上，CSL在盘前宣布，将启动一项临床试验工作，旨在验证其采用下一代Horizon 2工艺生产的免疫球蛋白的有效性和安全性。这一举措标志着公司在该关键领域的技术创新迈入临床验证阶段，有望进一步提升产品竞争力和市场前景，从而提振了投资者信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150998107","title":"CSL有限公司将开展临床试验，验证下一代Horizon 2工艺生产的免疫球蛋白有效性与安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=1150998107","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150998107?lang=zh_cn&edition=fundamental","pubTime":"2026-07-29 07:22","pubTimestamp":1785280928,"startTime":"0","endTime":"0","summary":"CSL有限公司宣布，将启动一项临床试验工作，旨在确认其采用下一代Horizon 2工艺生产的免疫球蛋白的有效性和安全性。这一举措标志着公司在该领域的技术创新迈入关键验证阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","CSL.AU","BK7511","BK7501","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103960538","title":"安登布里（Andembry）展现良好安全性；多数患者在12个月治疗期内未出现发作","url":"https://stock-news.laohu8.com/highlight/detail?id=1103960538","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103960538?lang=zh_cn&edition=fundamental","pubTime":"2026-07-27 21:01","pubTimestamp":1785157276,"startTime":"0","endTime":"0","summary":"CSL公司旗下的安登布里（Andembry）在安全性方面表现令人满意。一项为期12个月的治疗数据显示，大多数患者在整个治疗周期内始终保持无发作状态。这一结果凸显了该药物的安全性与疗效潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","CSL.AU","BK7508","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175437809","title":"CSL公布Andembry®治疗儿童遗传性血管性水肿IIIb期积极结果，支持扩大儿科适应症申报","url":"https://stock-news.laohu8.com/highlight/detail?id=1175437809","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175437809?lang=zh_cn&edition=fundamental","pubTime":"2026-07-27 21:01","pubTimestamp":1785157269,"startTime":"0","endTime":"0","summary":"CSL LIMITED（CSL.AU）近日宣布，其针对Andembry®（Garadacimab-Gxii）在儿童遗传性血管性水肿（HAE）患者中开展的IIIb期临床研究，取得了积极的顶线结果。这些数据将有力支持该公司计划中的扩大儿科适应症申报工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","CSL.AU","BK7067","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181965912","title":"欧盟就赛诺菲针对竞争对手流感疫苗可能存在的反竞争行为征集反馈意见","url":"https://stock-news.laohu8.com/highlight/detail?id=1181965912","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181965912?lang=zh_cn&edition=fundamental","pubTime":"2026-07-08 17:46","pubTimestamp":1783503996,"startTime":"0","endTime":"0","summary":"欧盟委员会正就赛诺菲公司提出的承诺方案公开征求意见，这些承诺旨在解决其可能存在的反竞争行为。该行为涉及针对特定脆弱患者群体的竞争对手流感疫苗。此举源于欧盟对赛诺菲可能滥用市场支配地位的调查。赛诺菲已提交一系列承诺，试图消除欧盟的竞争担忧。欧盟委员会现邀请市场参与者、竞争对手及公众在指定期限内，对这些承诺措施能否有效恢复相关市场的公平竞争环境提出反馈。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","CSL.AU","BK7511","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133109014","title":"赛诺菲回应欧盟调查：坚信自身行为始终完全符合所有适用法律法规","url":"https://stock-news.laohu8.com/highlight/detail?id=1133109014","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133109014?lang=zh_cn&edition=fundamental","pubTime":"2026-06-26 18:21","pubTimestamp":1782469273,"startTime":"0","endTime":"0","summary":"针对欧盟的调查，赛诺菲发言人表示，公司坚信其过去及当前的所有行为均完全符合所有适用的法律与法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7501","BK7508","BK7067","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177213732","title":"赛诺菲就欧盟调查发表声明：在整个过程中与欧盟委员会保持全面合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1177213732","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177213732?lang=zh_cn&edition=fundamental","pubTime":"2026-06-26 18:20","pubTimestamp":1782469218,"startTime":"0","endTime":"0","summary":"赛诺菲发言人针对欧盟调查一事表示，公司正与欧盟委员会保持全面合作，并将在整个过程中持续提供所需信息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","CSL.AU","BK7511","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646794508","title":"分析-2025年，随着高价基因疗法上市数量减少，美国新药价格出现下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2646794508","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646794508?lang=zh_cn&edition=fundamental","pubTime":"2026-06-25 18:01","pubTimestamp":1782381707,"startTime":"0","endTime":"0","summary":"分析-2025年，随着高价基因疗法上市数量减少，美国新药价格出现下降2025年获FDA批准的药品年均标价中位数为216,000美元2025年，FDA批准了51种新药，其中包括5种细胞和基因疗法2025年获批药物中，小分子药物占比超过67%，高于2024年的62%Deena Beasley路透6月25日-一项最新分析显示，2025年美国监管机构批准的处方药上市价格虽较上年有所下降，但受罕见病高价药物影响，中位数仍高达216,000美元。基因疗法通常只需给药一次，其价格可能高达数百万美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL4S42X0VU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK4585","BK4539","BK4588","LENZ","IONS","IE00BN0W2T93.GBP","BK4533","BK4139","ALNY","BK4007","LU0320765992.SGD","BK4548","LU0889565916.HKD","BK4532","IE00BN0W2W23.USD","LU0154245756.USD","BK7501","LU0882574055.USD","ABEO","BK7511","LU0823416689.USD","LU0154245673.USD","IE00BN0W2V16.EUR","BK7067","NTI.AU","BK7007","JAZZ","BK7508","LU0109394709.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646810778","title":"得克萨斯州训练中心爆发疫情后，美军要求部分人员接种流感疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2646810778","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646810778?lang=zh_cn&edition=fundamental","pubTime":"2026-06-25 02:27","pubTimestamp":1782325631,"startTime":"0","endTime":"0","summary":"得克萨斯州训练中心爆发疫情后，美军要求部分人员接种流感疫苗路透6月24日-美国军方已恢复要求部分军人接种流感疫苗，这与国防部长皮特·赫格塞斯两个月前发布的、将接种定为自愿的指导方针形成例外。赫格塞斯今年4月曾表示，根据五角大楼的新疫苗政策，所有美军人员每年接种流感疫苗将  成为自愿行为。此前，接种流感疫苗曾是强制性的，并被视为部队战备的关键环节。世界卫生组织建议6个月及以上人群接种流感疫苗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nL4T42W1N4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0171276677.USD","LU0545039389.USD","LU2539964713.USD","LU0345777147.USD","LU0289739699.SGD","LU2279689827.SGD","LU2293690249.USD","LU0997586515.USD","LU1104425308.USD","LU0310799852.SGD","LU0047473722.EUR","LU1119994496.HKD","LU0526926950.USD","LU0792757196.USD","LU1291159041.SGD","LU0708994859.HKD","LU1323610961.USD","LU0211326755.USD","LU1153585028.USD","LU1019632923.USD","LU2324357040.USD","LU0310800379.SGD","LU2133065610.SGD","03165","LU1481600234.SGD","LU1989772840.SGD","LU2433249047.HKD","LU1064927863.SGD","LU0964806797.USD","LU0052756011.USD","AZN.UK","LU2237443549.SGD","LU0266013472.USD","LU2125909247.SGD","LU0640478417.SGD","LU1019634622.SGD","LU1046234339.USD","LU1301847155.USD","LU1267930813.SGD","LU0390134368.USD","IE00BKPKM643.USD","LU0949170772.SGD","LU0211328371.USD","BK5011","IE00B3T34201.USD","LU0128525689.USD","LU2091194634.USD","LU1051770623.HKD","CSL.AU","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644044607","title":"FDA顾问委员会支持莫德纳mRNA流感疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2644044607","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644044607?lang=zh_cn&edition=fundamental","pubTime":"2026-06-18 18:00","pubTimestamp":1781776840,"startTime":"0","endTime":"0","summary":"更新版 3-FDA顾问委员会支持莫德纳mRNA流感疫苗在第4段中补充了股价走势，在第7段中补充了专家评论，在第10、12段中补充了分析师评论FDA顾问委员会认可mFlusiva对50岁及以上成年人的疗效该机构最初曾驳回莫德纳公司的申请预计FDA将于8月5日前作出批准决定这将成为美国首款季节性流感mRNA疫苗Christy Santhosh/Mariam Sunny","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nL4T42Q0TH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0077335932.USD","LU0211326839.USD","LU0058720904.USD","LU0158827948.USD","LU1196032939.SGD","LU1084165304.USD","MRNY","IE00B4R5TH58.HKD","SG9999001176.USD","MRNX","LU0889566641.SGD","LU0203347892.USD","LU0661504455.SGD","LU0128525929.USD","LU0889565080.SGD","LU1267930573.SGD","SG9999001176.SGD","IE00BJT1NW94.SGD","LU2237443895.HKD","LU1019634622.SGD","LU0784384876.USD","LU1496350502.SGD","LU0784385840.USD","LU0960981461.USD","LU0784383803.USD","MRNA","LU1153585028.USD","LU2293690082.USD","BK4534","LU0289739699.SGD","AZN.UK","LU0553294199.USD","03165","BK4551","LU1880407215.USD","LU0310799852.SGD","IE00BKPKM643.USD","LU0784385170.HKD","CSL.AU","LU1487256676.USD","BK4585","LU1496350171.SGD","LU1057294990.SGD","LU0128525689.USD","LU1983299246.USD","LU0029864427.USD","SG9999013999.USD","LU0171293334.USD","LU0920840948.USD","LU1078025761.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643520595","title":"数据简报-全球制药企业斥资数十亿美元以扩大在美国的市场份额","url":"https://stock-news.laohu8.com/highlight/detail?id=2643520595","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643520595?lang=zh_cn&edition=fundamental","pubTime":"2026-06-15 20:41","pubTimestamp":1781527269,"startTime":"0","endTime":"0","summary":"路透6月15日 - 全球制药企业正扩大在美国的业务布局，承诺投入数十亿美元以提升该国的生产能力和研发实力。该公司于6月表示，已在佛罗里达州杰克逊维尔市投资约10亿美元，以加强其眼科护理业务在美国本土的制造能力。默克动物保健部门将投资8.95亿美元，用于扩建其位于堪萨斯州的制造和研发基地，这是该公司截至2028年总额达90亿美元的美国投资计划的一部分。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL4T42N15M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242652126.USD","IE000SO60NU8.SGD","IE00BJJMRZ35.SGD","IE00B3T34201.USD","LU1037948541.HKD","LU0133085943.USD","LU0128525929.USD","LU0965509101.SGD","LU0471298694.HKD","BIIB","LU0211331839.USD","LU0980610538.SGD","IE00BFSS8Q28.SGD","LU1623119135.USD","LU2237443549.SGD","LU0353189763.USD","LU1983299246.USD","LU1267930490.SGD","LU1974910355.USD","SGXZ57979304.SGD","IE0002270589.USD","LLY","LU0321505439.SGD","IE0004445015.USD","LU2211815571.USD","LU0456855351.SGD","LU1196500208.SGD","IE0004445239.USD","LU1829250122.USD","LU2125154778.USD","IE00BDGV0183.EUR","LU0823416689.USD","LU1093756325.SGD","LU1989772923.USD","LU2125154935.USD","LU2505996681.GBP","SGXZ51526630.SGD","LU0949170772.SGD","LU1244550494.USD","IE00BLSP4452.SGD","IE00BN29S564.USD","LU1935042991.SGD","IE000F7OJYX1.SGD","LU2491049909.HKD","LU0965509283.SGD","LU0097036916.USD","IE00BVYPNW00.USD","LU2129689514.USD","LU2087625088.SGD","LU2237443465.HKD","IE00B7KXQ091.USD","LU1868836914.USD","IE000MB6IJN5.SGD","LU1035775433.USD","LU0471298777.SGD","LU1934455194.USD","LU2023250330.USD","IE0002141913.USD","LU0158827781.USD","BK4599","LU0792757196.USD","LU2271345857.HKD","IE00BFSS7M15.SGD","LU2087621335.USD","GB00BDT5M118.USD","LU0070302665.USD","LU2750360997.AUD","LU1923622614.USD","SG9999015341.SGD","LU1003077747.HKD","IE00BBT3K403.USD","LU0385154629.USD","LU0345770308.USD","BK7501","LU0345769128.USD","LU0943347566.SGD","LU1043141123.HKD","LU0256863902.USD","LU2168564495.EUR","LU1066053197.SGD","LU2324357040.USD","LU1221951046.USD","LU1571399168.USD","LU2264538146.SGD","LU2471134879.HKD","BK7511","LU2063271972.USD","LU1934455863.HKD","LU0061475181.USD","LU0353189680.USD","IE00BJLML261.HKD","IE0000B7K699.USD","LU0170899867.USD","LU2596442595.SGD","LU0432979614.USD","LU0868494617.USD","IE00BN8TJ469.HKD","IE0009355771.USD","LU1585245621.USD","LU2360106947.USD","LU0070217475.USD","LU2750360641.GBP","LU1670628061.USD","LU2125909247.SGD","SG9999003800.SGD","LU0985481810.HKD","LU0234572021.USD","LU1712237335.SGD","LU0354030438.USD","LU2242646821.SGD","BK4139","LU1430594728.SGD","LU0889565916.HKD","LU2552382058.USD","LU1061106388.HKD","LU0310800379.SGD","SG9999015986.USD","IE00BLSP4239.USD","IE000WAW04H5.SGD","LU1064131342.USD","IE00B1XK9C88.USD","LU2028103732.USD","LU2111349929.HKD","LU2746668974.SGD","LU2471134952.CNY","LU2236285917.USD","LU0942090050.USD","LU1699723380.USD","IE00B775H168.HKD","IE00BSNM7G36.USD","LU0964807845.USD","LU1674673428.USD","LU1201861249.SGD","LU1548497426.USD","IE00BJJMRY28.SGD","LU0823434740.USD","LU0648001328.SGD","LU0321505868.SGD","LU1496350171.SGD","LU1868837136.USD","LU0320765646.SGD","IE00BJJMRX11.SGD","LU1116320737.USD","LU1162221912.USD","LU0114720955.EUR","LU0122379950.USD","LU0208291251.USD","LU0708995401.HKD","LU1989772840.SGD","BK4532","LU2237438978.USD","LU2430703095.HKD","LU0553294199.USD","LU0289961442.SGD","LU0965509010.AUD","LU0210528500.USD","LLYX","LU0106261372.USD","LU0130102774.USD","LU0053666078.USD","LU1032955483.USD","LU0225283273.USD","LU1280957306.USD","LU2756315318.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0320765059.SGD","IE00B894F039.SGD","LU0545562505.USD","SGXZ99366536.SGD","IE000BZT7R73.USD","SG9999015358.SGD","IE0001KFT4U8.USD","LU1839511570.USD","LU0289739699.SGD","LU0320765992.SGD","LU1066051225.USD","LU2456880835.USD","LU0316494557.USD","LU2168564065.EUR","LU0225771236.USD","LU0787776722.HKD","SG9999015978.USD","LU2129689431.USD","SG9999001176.SGD","LU2592432038.USD","BK4585","IE00BK4W5M84.HKD","LU0256863811.USD","LU2552382215.SGD","GILD","BK4588","LU2471134796.USD","LU2360032135.SGD","SG9999014880.SGD","LU1917777945.USD","LU1023059063.AUD","LU2357627491.SGD","LU0689472784.USD","IE00B4R5TH58.HKD","LU2237443978.SGD","LU1145028129.USD","JNJ","LU0203202063.USD","ELIS","AMGN","LU0098860793.USD","LU2491050154.USD","LU1267930813.SGD","SG9999018865.SGD","LU0211328371.USD","LU0345769631.USD","BK4516","BK4550","LU2023251221.USD","LU0417517546.SGD","LU0323591593.USD","LU1894683264.USD","LU1496350502.SGD","LU0683600562.USD","LU0889566641.SGD","LU2125909593.SGD","LU2265009873.SGD","LU2746668461.USD","LU0672654240.SGD","SG9999018857.SGD","LU1629891620.HKD","IE00B19Z3581.USD","LU2133065610.SGD","LU1232071149.USD","LU2089283258.USD","IE00B1BXHZ80.USD","LU0426417589.USD","LU0823434583.USD","AZN","LU0466842654.USD","LU0225284248.USD","IE00B42XCP33.USD","LU2417539215.USD","LU0265550359.USD","IE00BJT1NW94.SGD","SG9999002224.SGD","LU0965508806.USD","LU0511384066.AUD","LU1804176565.USD","LU0029864427.USD","LU2108987350.USD","LU0203345920.USD","BK4533","LU0861579265.USD","LU2237443895.HKD","LU0079474960.USD","SG9999015945.SGD","LU0094547139.USD","BK4007","LLII","LU1267930730.SGD","LU2347655156.SGD","LU2430703178.SGD","LU1032466523.USD","SG9999013999.USD","SG9999001440.SGD","IE00B2B36J28.USD","IE00BK4W5L77.USD","LU2602419157.SGD","LU2461242641.AUD","LU2361044949.HKD","IE00BFTCPJ56.SGD","LU0211327993.USD","LU1929549753.HKD","LU1267930573.SGD","LU0069063385.USD","LU2491050071.SGD","LU1221951129.SGD","LU1720051108.HKD","LU0426412945.USD","GSKH","LU1989771016.USD","IE00B7SZLL34.SGD","LU0234570918.USD","LU2023250843.SGD","LU0882574139.USD","LU0708994859.HKD","LU0130517989.USD","LU0354030511.USD","LU2487616109.SGD","LU0738911758.USD","LU1883839398.USD","LU0198837287.USD","LU1941712348.USD","LU0109394709.USD","LU1732799900.SGD","LU0310799852.SGD","LU1732800096.USD","SG9999014914.USD","SG9999001176.USD","LLYZ","LU1868836591.USD","SG9999014898.SGD","SG9999017495.SGD","SG9999014567.USD","LU1074936037.SGD","LU1914381329.SGD","LU0266013472.USD","LU0859254822.USD","LU1066051811.HKD","AZNH","LU2106854487.HKD","BK4581","LU2112291526.USD","LU1093756168.USD","IE00BKDWB100.SGD","LU0058720904.USD","LU0306807586.USD","LU1057294990.SGD","LU0820561818.USD","IE00BVYPNV92.GBP","LU2023250504.SGD","LU0868494708.USD","LU1720051017.SGD","LU2089284900.SGD","LU1551013425.SGD","LU1127390331.HKD","LU2433249047.HKD","BK4592","LU0472753341.HKD","LU1778281490.HKD","LU2168564149.EUR","SG9999014906.USD","SG9999015952.SGD","LU2213496289.HKD","LU0306806265.USD","LU2462157665.USD","LU1043141396.HKD","LU1121112475.USD","SG9999014559.SGD","LU0820562030.AUD","LU0124676726.USD","LU0265550946.USD","IE00B19Z3B42.SGD","LU0320765489.SGD","LU1035773651.USD","LU0057025933.USD","BK4559","LU0109391861.USD","LU1059921491.USD","LU0994945656.USD","LU0661504455.SGD","LU0238689110.USD","LU0912757837.SGD","LU0158827948.USD","CSL.AU","LU1894683348.USD","LU1988902786.USD","SG9999002232.USD","LU1366192091.USD","LU2361045086.USD","LU2237443622.USD","IE00BWXC8680.SGD","IE00B19Z9P08.USD","LU1814569148.SGD","LU1934455277.USD","LU0345770993.USD","LU0096364046.USD","LU1037948897.HKD","LU0795875086.SGD","LU0640476718.USD","SG9999014542.SGD","LU1069344957.HKD","LU1941712264.USD","LU2756315664.SGD","LU1244550221.USD","IE00BGHQF631.EUR","BK4568","LU1868836757.USD","BK4578","LU2168563687.JPY","BK7508","SG9999014575.USD","LU2552382132.HKD","LU1291159041.SGD","LU0210536198.USD","PFE","LU0882574055.USD","SGXZ81514606.USD","MRK","LU2089984988.USD","LU1066051498.USD","LU2896262040.SGD","IE00BKPKM429.USD","LU1718418525.SGD","LU2129689605.HKD","LU1670627923.USD","LU0477156953.USD","GSK.UK","LU2468319806.SGD","BK4534","BK4583","LU1868837300.USD","LU0786609619.USD","LU1674673691.USD","IE00BFXG1179.USD","IE0034235303.USD","LU0689626769.HKD","LU2168564222.USD","LU2471134523.USD","LU1261432733.SGD","LU0985320562.USD","LU2237443382.USD","LU2403377893.USD","LU2505996509.AUD","BK4566","LU1551013342.USD","LU0006306889.USD","BK4504","LU0545039389.USD","IE0005OL40V9.USD","SG9999011175.SGD","ELIL","LU0203201768.USD","IE000M9KFDE8.USD","LU1069347547.HKD","LU1244550577.SGD","LU0289739343.SGD","LU0795875169.SGD","SGXZ31699556.SGD","LU0820561909.HKD","LU1228905037.USD","ABBV","LU2430703251.USD","LU1228905540.USD","LU0203347892.USD","LU2361044865.SGD","IE00B19Z9Z06.USD","04332","IE00B4JS1V06.HKD","LU1323610961.USD","LU1506573853.SGD","BK7067","LU1116320901.HKD","IE00B3PB1722.GBP","LU2357305700.SGD","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109452273","title":"异动解读 | 英国批准AUJEMFLU流感疫苗，CSL LIMITED盘中大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109452273","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109452273?lang=zh_cn&edition=fundamental","pubTime":"2026-06-05 11:36","pubTimestamp":1780630616,"startTime":"0","endTime":"0","summary":"CSL LIMITED(CSL.AU)今日盘中大涨5.02%，引起了市场的广泛关注。消息面上，英国药品和健康产品管理局（MHRA）已批准佐剂三价流感疫苗AUJEMFLU的上市许可，该疫苗旨在为50岁及以上的成年人群提供针对流感的保护。此次批准为相关公司带来了进一步的市场覆盖机会，增强了市场对其业务增长潜力的信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104796496","title":"英国MHRA批准AUJEMFLU用于50岁及以上成人流感防护","url":"https://stock-news.laohu8.com/highlight/detail?id=1104796496","media":"投资观察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104796496?lang=zh_cn&edition=fundamental","pubTime":"2026-06-05 00:28","pubTimestamp":1780590511,"startTime":"0","endTime":"0","summary":"英国药品和健康产品管理局（MHRA）已批准佐剂三价流感疫苗AUJEMFLU的上市许可，该疫苗旨在为50岁及以上的成年人群提供针对流感的保护。\n此次批准为相关公司带来了进一步的市场覆盖机会。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","CSL.AU","BK7067","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640926067","title":"热门话题-尽管表现欠佳，晨星仍维持对CSL的公允价值评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2640926067","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640926067?lang=zh_cn&edition=fundamental","pubTime":"2026-06-03 05:33","pubTimestamp":1780436025,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nL4T42A1S7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7511","BK7067","MORN","BK4598","BK4112","LU1878469433.USD","LU2065731478.USD","BK7508","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163020107","title":"澳大利亚TGA：苯青霉素注射剂产品将逐步停产，600毫克规格自11月30日起首当其冲，原因系商业考量","url":"https://stock-news.laohu8.com/highlight/detail?id=1163020107","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163020107?lang=zh_cn&edition=fundamental","pubTime":"2026-05-27 15:05","pubTimestamp":1779865555,"startTime":"0","endTime":"0","summary":"澳大利亚治疗用品管理局（TGA）发布通告，苯青霉素注射剂产品将基于商业原因逐步退出市场。停产计划将自11月30日起开始实施，首当其冲的将是600毫克规格的产品。此举意味着该规格的供应将逐步减少并最终停止。后续其他规格产品的停产安排，预计将根据商业评估结果进一步公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7501","BK7508","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187424614","title":"澳大利亚TGA：未来或将有更多本土注册的青霉素钠注射剂品牌上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1187424614","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187424614?lang=zh_cn&edition=fundamental","pubTime":"2026-05-27 15:05","pubTimestamp":1779865545,"startTime":"0","endTime":"0","summary":"澳大利亚治疗商品管理局（TGA）表示，未来市场上有望出现更多在澳大利亚注册的替代性青霉素钠注射剂品牌。这一预期旨在增加关键抗生素的供应来源，提升医疗系统的药品可及性与选择多样性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7508","BK7501","BK7511","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129937392","title":"澳大利亚TGA：特定苄星青霉素钠注射液产品将持续供应至库存耗尽","url":"https://stock-news.laohu8.com/highlight/detail?id=1129937392","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129937392?lang=zh_cn&edition=fundamental","pubTime":"2026-05-27 15:05","pubTimestamp":1779865544,"startTime":"0","endTime":"0","summary":"澳大利亚药品管理局（TGA）发布通告，明确特定批次的苄星青霉素钠注射液产品将继续供应，直至现有库存完全耗尽。这一决定旨在确保医疗服务的连续性，为依赖该药品的患者提供明确的供应预期。TGA将持续监控库存与分发情况，以保障公共卫生需求得到满足。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","CSL.AU","BK7508","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108861620","title":"CSL加拿大宣布首例加拿大患者于安大略省接受Hemgenix®血友病B基因疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1108861620","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108861620?lang=zh_cn&edition=fundamental","pubTime":"2026-05-20 18:01","pubTimestamp":1779271295,"startTime":"0","endTime":"0","summary":"CSL加拿大公司宣布，首例加拿大患者已在安大略省成功接受了Hemgenix®（Etranacogene Dezaparvovec）基因疗法，用于治疗血友病B。这一里程碑事件标志着该创新疗法在加拿大临床应用的正式开启。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","BK7511","CSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169753180","title":"泛美卫生组织签署协议 为拉美及加勒比地区预留大流行流感疫苗供应","url":"https://stock-news.laohu8.com/highlight/detail?id=1169753180","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169753180?lang=zh_cn&edition=fundamental","pubTime":"2026-05-13 02:31","pubTimestamp":1778610671,"startTime":"0","endTime":"0","summary":"泛美卫生组织（PAHO）已签署一项关键协议，旨在为拉丁美洲及加勒比地区预先保留大流行性流感疫苗的供应。此举旨在加强该区域应对未来潜在流感大流行的准备能力，确保疫苗的及时获取与分配。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","CSL.AU","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152457110","title":"异动解读 | 花旗下调评级与目标价，CSL盘中大跌5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152457110","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152457110?lang=zh_cn&edition=fundamental","pubTime":"2026-05-12 08:38","pubTimestamp":1778546311,"startTime":"0","endTime":"0","summary":"CSL LIMITED（CSL.AU）今日盘中大跌5.74%，引发了市场关注。消息面上，花旗集团将CSL的评级从“买入”下调至“中性”，并将其目标价从200澳元大幅下调至110澳元，同时下调了对该公司2026财年的利润预期。此外，投资研究机构晨星也下调了对CSL未来十年的营收和净利润预测。更为直接的是，CSL公司自身在近期下调了年度利润预期，并警告将计提高达50亿澳元的减值准备。晨星分析师指出，鉴于销售势头不足，公司的高营收增长前景难以令人信服，并敦促公司聘请新任首席执行官并提出清晰的发展愿景以重振旗鼓。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":45,"code":"91000000","status":"200"}]}}